This statistic displays the global respiratory therapy market by condition based on the MAT (moving annual total) until the third quarter of 2023 (October 2022 to September 2023). In that year, the global asthma therapy market generated around 25 billion U.S. dollars. Asthma is a major cause of morbidity and mortality globally and it is thought to have become more prevalent in the last decades. Fixed combination doses of preventative and symptomatic treatments are used to combat moderate to severe asthma.
Distribution of global respiratory and immunology market by condition in 2022-2023
(in billion U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
AstraZeneca. (February 20, 2024). Distribution of global respiratory and immunology market by condition in 2022-2023 (in billion U.S. dollars) [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/312329/worldwide-respiratory-therapy-market-by-condition/
AstraZeneca. "Distribution of global respiratory and immunology market by condition in 2022-2023 (in billion U.S. dollars)." Chart. February 20, 2024. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/312329/worldwide-respiratory-therapy-market-by-condition/
AstraZeneca. (2024). Distribution of global respiratory and immunology market by condition in 2022-2023 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/312329/worldwide-respiratory-therapy-market-by-condition/
AstraZeneca. "Distribution of Global Respiratory and Immunology Market by Condition in 2022-2023 (in Billion U.S. Dollars)." Statista, Statista Inc., 20 Feb 2024, https://www.statista.com/statistics/312329/worldwide-respiratory-therapy-market-by-condition/
AstraZeneca, Distribution of global respiratory and immunology market by condition in 2022-2023 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/312329/worldwide-respiratory-therapy-market-by-condition/ (last visited July 22, 2024)
Distribution of global respiratory and immunology market by condition in 2022-2023 (in billion U.S. dollars) [Graph], AstraZeneca, February 20, 2024. [Online]. Available: https://www.statista.com/statistics/312329/worldwide-respiratory-therapy-market-by-condition/
